Wasman Jane
- SEC CIK
- 0001352455
No open-market purchases or sales filed in the past year.
Current role at each company
- RIGL Rigel Pharmaceuticals IncDirectoras of May 19, 2026
- SLS SELLAS Life Sciences Group, Inc.Directoras of Jan 9, 2026
- ATHX Athersys, IncDirectoras of Jan 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Wasman Jane as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SLS SELLAS Life Sciences Group, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2025 (view filing) | May 30 | 3 days | Wasman JaneDirector | PPurchase | +20.0K | $1.69 | +$33.8K | +192.3%30.4K after |